Inactive Instrument
Sector Cardium Therapeutics Inc NYSE
Stocks
CXM
US1419163043
Biotechnology & Medical Research
|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 30/03/22 | Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 03/09/21 | Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.16% | +4.16% | +8.78% | +36.08% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.68B | |
| -11.78% | -12.10% | -14.55% | -7.50% | +3.21% | +7.65% | +58.42% | +189.78% | +4,932.65% | 58.7B | |
| -1.44% | +1.57% | +2.41% | -0.63% | +5.88% | +4.52% | +32.73% | -17.67% | +205.31% | 48.36B | |
| +0.50% | -2.14% | -4.36% | +5.47% | +152.19% | +331.33% | +702.20% | +621.26% | - | 43.05B | |
| -0.72% | -3.99% | -3.61% | +23.95% | +14.51% | +28.50% | +29.94% | +5.86% | +224.83% | 42.48B | |
| +0.34% | -0.52% | +1.61% | +17.82% | +19.82% | +6.56% | +109.35% | +1.12% | +1,043.28% | 41.39B | |
| -0.11% | +1.96% | -3.03% | +3.70% | +5.81% | +9.19% | +52.66% | +4.65% | +144.87% | 31.29B | |
| -0.50% | -3.10% | -8.20% | +1.02% | +0.05% | -10.19% | -14.35% | -61.37% | - | 23.93B | |
| -3.32% | -10.86% | -19.44% | -9.84% | -41.54% | -37.32% | +316.28% | +268.49% | +598.28% | 22.22B | |
| -3.22% | +2.43% | +12.10% | +26.55% | +18.40% | +14.67% | -1.52% | -14.47% | +111.27% | 22.24B | |
| +0.22% | -3.19% | +2.19% | +10.61% | +7.58% | +13.61% | +145.55% | +212.82% | +1,900.17% | 16.87B | |
| -1.26% | -1.67% | -10.31% | -9.80% | +177.32% | +133.17% | +348.50% | +1,873.29% | +667.33% | 15.67B | |
| -0.08% | +2.58% | +7.39% | +14.02% | +22.53% | +22.73% | +46.93% | -27.73% | +84.93% | 14.87B | |
| +1.04% | +0.25% | -15.58% | -14.44% | - | - | - | - | - | 15B | |
| -1.53% | +1.79% | +4.09% | +31.32% | +50.54% | +76.54% | +55.23% | -27.91% | +261.63% | 14.34B | |
| +0.19% | +0.05% | -0.97% | +2.38% | +33.33% | +47.46% | +163.01% | +171.06% | +351.27% | 14.48B | |
| +3.70% | +6.15% | +1.96% | +13.04% | +2.63% | -19.47% | +919.89% | +256.86% | +50.59% | 14.36B | |
| -2.26% | -14.10% | +8.87% | +17.07% | +19.14% | -24.36% | - | - | - | 12.69B | |
| +1.48% | -3.48% | -0.47% | -2.75% | -9.95% | -12.09% | -31.57% | -38.22% | +107.78% | 12.66B | |
| Average | -1.01% | -1.44% | -1.64% | +8.32% | +31.45% | +35.66% | +178.08% | +201.61% | +763.16% | 28.38B | |
| Weighted average by Cap. | -1.21% | -1.20% | -1.63% | +10.38% | +36.34% | +44.52% | +158.22% | +156.71% | +1,154.81% |
- Stock Market
- Stocks
- CRXM Stock
- CXM Stock
- Sector Cardium Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
